<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04327375</url>
  </required_header>
  <id_info>
    <org_study_id>3/2020</org_study_id>
    <nct_id>NCT04327375</nct_id>
  </id_info>
  <brief_title>Effect of Body Composition on Thyroid Hormone Levels Among Overweight and Obese Subjects</brief_title>
  <acronym>3/2020</acronym>
  <official_title>Effect of Body Composition on Thyroid Hormone Levels Among Overweight and Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was aimed at investigating the relationship between body composition and thyroid
      hormone levels in overweight and obese subjects (BMIâ‰¥25 Kg/m2)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects were enrolled at the first examination whether they were not taking any medication,
      including oral contraceptives or drugs for osteoporosis, and free of significant medical
      illnesses, except obesity. Exclusion criteria were history of endocrinological diseases
      (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), chronic inflammatory
      diseases, stable known hypertension, angina pectoris, stroke, transient ischemic attack,
      heart infarction, congenital heart disease, malignancies, chronic inflammatory diseases,
      renal and liver failure, angina pectoris, myocardial infarction, heart failure, congenital
      heart diseases, minor and major stroke, and inherited thrombocytopenias and other major
      malignancies. Subjects were examined by means of the medical history, hormonal, metabolic and
      routine hematochemical parameters. The investigators provided for a clinical baseline
      evaluation that included extemporaneous ambulatory blood pressure (BP), bioimpedance and a
      physical assessment of body weight, Body Mass Index (BMI) and Waist Circumference (WC) as
      anthropometric parameters.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Thyroid hormones (FT3, FT4)</measure>
    <time_frame>Baseline</time_frame>
    <description>FT3 (pg/mL), FT4 (pg/mL) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>skeletal muscle mass</measure>
    <time_frame>Baseline</time_frame>
    <description>skeletal muscle mass (kg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TSH</measure>
    <time_frame>At baseline</time_frame>
    <description>TSH (mU/L) concentration in serum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>Baseline</time_frame>
    <description>Vitamin D (ng/mL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>Baseline</time_frame>
    <description>Insulin (mIU/L) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eGFR (estimated glomerular filtration rate)</measure>
    <time_frame>Baseline</time_frame>
    <description>eGFR (ml/min/1.73 mq)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinin</measure>
    <time_frame>Baseline</time_frame>
    <description>Creatinin (mg/dl) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>Baseline</time_frame>
    <description>Total cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>Baseline</time_frame>
    <description>HDL cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>Baseline</time_frame>
    <description>LDL cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>Baseline</time_frame>
    <description>BMI (kg/m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>Baseline</time_frame>
    <description>Height in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline</time_frame>
    <description>Weight in kilograms</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">250</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>observational</arm_group_label>
    <description>observational</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Observational</description>
    <arm_group_label>observational</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who came to the Outpatient Clinic of Nutrition at the National Institute of
        Gastroenterology &quot;S. de Bellis,&quot; Research Hospital, Castellana Grotte, Italy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight or obesity (BMI&gt; 25 Kg/m2)

        Exclusion Criteria:

          -  Any kind of drug

          -  Hypertension

          -  Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism,
             etc.),

          -  Chronic inflammatory diseases

          -  Renal failure

          -  Liver failure

          -  Angina pectoris

          -  Myocardial infarction and heart failure

          -  Genetic heart diseases

          -  Thrombocytopenias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Roberta Zupo</name>
      <address>
        <city>Bari</city>
        <state>BA</state>
        <zip>70123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 27, 2020</study_first_submitted>
  <study_first_submitted_qc>March 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2020</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</investigator_affiliation>
    <investigator_full_name>Gianluigi Giannelli</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

